Comments

Inhibitor Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Inhibitor Therapeutics (INTI) operate in?

Inhibitor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

INTIOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0600

At close: May 13 EDT

Inhibitor Therapeutics (INTI) Forecast

News Earnings Inhibitor Therapeutics (INTI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Inhibitor Therapeutics Stock Price, Quotes and Forecasts | OTC:INTI | Benzinga

Explore Inhibitor Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INTI.

Open	-
Close	-
Volume / Avg.	0 / 36.71K
Day Range	- - -
52 Wk Range	0.04 - 0.14
Market Cap	$10.34M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 36.71K
Day Range	- - -
52 Wk Range	0.04 - 0.14
Market Cap	$10.34M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About Inhibitor Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Inhibitor Therapeutics Inc is a pharmaceutical development company that is focused on developing and...

Got Questions? Ask

How is INTI's EV/EBITDA ratio?

What is INTI's all-time high price?

What is INTI's current price trend?

What is INTI's net income trend?

What’s the latest news on INTI?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Inhibitor Therapeutics (INTI) stock?

You can purchase shares of Inhibitor Therapeutics (OTCQB:INTI) through any online brokerage.

View our list of the best stock brokerages

Who are Inhibitor Therapeutics (INTI) competitors?

There are no as such competitors for Inhibitor Therapeutics.

What is the forecast, or price target, for Inhibitor Therapeutics (INTI) stock?

There is no analysis for Inhibitor Therapeutics to provide a consensus price target.

What is the current price for Inhibitor Therapeutics (INTI)?

The stock price for Inhibitor Therapeutics (OTCQB: INTI) is $0.06 last updated May 13, 2025 at 3:54 PM EDT.

Does Inhibitor Therapeutics (INTI) pay a dividend?

There are no upcoming dividends for Inhibitor Therapeutics.

When is Inhibitor Therapeutics (OTCQB:INTI) reporting earnings?

Inhibitor Therapeutics does not have any upcoming earnings scheduled.

Is Inhibitor Therapeutics (INTI) going to split?

There is no upcoming split for Inhibitor Therapeutics.

What sector and industry does Inhibitor Therapeutics (INTI) operate in?

Inhibitor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.